China Pharmacy Management System Market

ID: MRFR/Pharma/47844-HCR
200 Pages
Satyendra Maurya
Last Updated: April 06, 2026
China Pharmacy Management System Market Research Report By Solution Type (Pharmacy Inventory Management System, Pharmacy Data Management System, Pharmacy Compounding Software System, Pharmacy Benefits Management System, Pharmacy Revenue Cycle Management System, Others), By Component (Software, Hardware, Services), By Deployment Mode (Web-Based, On-Premise) and By End User (Inpatient Pharmacies, Outpatient Pharmacies) - Growth & Industry Forecast 2025 To 2035
China Pharmacy Management System Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)9.65%
2024 Market Size$ 6.12 Billion
2025 Market Size$ 6.77 Billion
2035 Market Size$ 16.85 Billion
Key Players
WeDoctor
Guangzhou Baiyunshan Pharmaceutical Holdings
Sinopharm Group
Shanghai Pharmaceuticals Holding
China National Pharmaceutical Group
Hunan Dingtai Pharmaceutical
Trends
  • Digital Transformation in Pharmacies
  • Regulatory Support for Innovation
  • Focus on Patient-Centric Services
Opportunities
  • Rising Focus on Data Analytics
  • Increasing Demand for Automation
  • Shift Towards Patient-Centric Care
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Billion)
      1. 4.1.1 Retail Pharmacy
      2. 4.1.2 Hospital Pharmacy
      3. 4.1.3 Online Pharmacy
      4. 4.1.4 Pharmacy Chain
      5. 4.1.5 Pharmaceutical Distribution
    2. 4.2 Healthcare, BY Deployment Type (USD Billion)
      1. 4.2.1 On-Premise
      2. 4.2.2 Cloud-Based
      3. 4.2.3 Hybrid
    3. 4.3 Healthcare, BY End User (USD Billion)
      1. 4.3.1 Pharmacists
      2. 4.3.2 Pharmacy Managers
      3. 4.3.3 Healthcare Providers
      4. 4.3.4 Patients
    4. 4.4 Healthcare, BY Functionality (USD Billion)
      1. 4.4.1 Inventory Management
      2. 4.4.2 Prescription Management
      3. 4.4.3 Billing and Invoicing
      4. 4.4.4 Reporting and Analytics
    5. 4.5 Healthcare, BY Integration (USD Billion)
      1. 4.5.1 Electronic Health Records
      2. 4.5.2 Supply Chain Management
      3. 4.5.3 Customer Relationship Management
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 WeDoctor (CN)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Guangzhou Baiyunshan Pharmaceutical Holdings (CN)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Sinopharm Group (CN)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Shanghai Pharmaceuticals Holding (CN)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 China National Pharmaceutical Group (CN)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Hunan Dingtai Pharmaceutical (CN)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Zhejiang Hisun Pharmaceutical (CN)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Jiangsu Hengrui Medicine (CN)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Tianjin Pharmaceutical Group (CN)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 CHINA MARKET ANALYSIS BY APPLICATION
    3. 6.3 CHINA MARKET ANALYSIS BY DEPLOYMENT TYPE
    4. 6.4 CHINA MARKET ANALYSIS BY END USER
    5. 6.5 CHINA MARKET ANALYSIS BY FUNCTIONALITY
    6. 6.6 CHINA MARKET ANALYSIS BY INTEGRATION
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    15. 6.15 HEALTHCARE, BY DEPLOYMENT TYPE, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY DEPLOYMENT TYPE, 2024 TO 2035 (USD Billion)
    17. 6.17 HEALTHCARE, BY END USER, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    19. 6.19 HEALTHCARE, BY FUNCTIONALITY, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY FUNCTIONALITY, 2024 TO 2035 (USD Billion)
    21. 6.21 HEALTHCARE, BY INTEGRATION, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY INTEGRATION, 2024 TO 2035 (USD Billion)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
      2. 7.2.2 BY DEPLOYMENT TYPE, 2026-2035 (USD Billion)
      3. 7.2.3 BY END USER, 2026-2035 (USD Billion)
      4. 7.2.4 BY FUNCTIONALITY, 2026-2035 (USD Billion)
      5. 7.2.5 BY INTEGRATION, 2026-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

China Pharmacy Management System Market Segmentation

China Pharmacy Management System Market By Application (USD Billion, 2026-2035)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
  • Pharmacy Chain
  • China Pharmacy Management System Market Distribution

China Pharmacy Management System Market By Deployment Type (USD Billion, 2026-2035)

  • On-Premise
  • China Pharmacy Management System Market-Based
  • Hybrid

China Pharmacy Management System Market By End User (USD Billion, 2026-2035)

  • Pharmacists
  • Pharmacy Managers
  • China Pharmacy Management System Market Providers
  • Patients

China Pharmacy Management System Market By Functionality (USD Billion, 2026-2035)

  • Inventory Management
  • Prescription Management
  • Billing and Invoicing
  • Reporting and Analytics

China Pharmacy Management System Market By Integration (USD Billion, 2026-2035)

  • Electronic Health Records
  • Supply Chain Management
  • Customer Relationship Management

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.